Ultrasound-Responsive Materials for Drug/Gene Delivery-Reference-Cited by-同舟云学术

Ultrasound-Responsive Materials for Drug/Gene Delivery

Published:2022-07-05 Issue: Volume: Page:101-112
ISSN:2790-0088
Container-title:Journal of Biomedical and Sustainable Healthcare Applications
language:en
Short-container-title:JBSHA

Author:

Girma Emily¹,Dunn Crystal¹

Affiliation:

1. Faculty of Medicine and Health Sciences, Columbus University, 3a Oeste, David, Panama.

Abstract

Due to its low risk, high accuracy, and deep penetration into tissue, Ultrasound (US) has become one of the most widely used methods in the diagnosis and treatment of disease. US is gaining more attention in the Drug/gene Delivery Systems (DDS) due to the countless benefits it offers in relations of site-precise delivery as well as spatial statementdelivery of medications/genetic factor. The most popular type of ultrasound-responsive delivery material is Microbubbles (MBs). Nanobubbles, droplets, micelles, as well as nanoliposomes are just some of the recent innovations in this area that serve as carriers. In order to encourage further research into ultrasound approachable materials as distributioncarters, we review recent successes with novel ultrasound receptive materials (Microbubbles (MBs), Micelles, Liposomes and Niosomes) and deliberate the challenges associated with using Ultrasound-Responsive Materials (US-RM) in Drug Delivery Systems (DDS).

Publisher

Anapub Publications

Link

https://anapub.co.ke/journals/jbsha/jbsha_pdf/2022/jbsha_volume_2-issue_2/JBSHA202202012.pdf

Reference35 articles.

1. D. Fu et al., “A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy,” Drug Deliv., vol. 28, no. 1, pp. 195–205, 2021.

2. C. A. Franco-Urquijo, J. Á. Navarro-Becerra, A. Ríos, and B. Escalante, “Release of vascular agonists from liposome-microbubble conjugate by ultrasound-mediated microbubble destruction: effect on vascular function,” Drug Deliv. Transl. Res., vol. 12, no. 5, pp. 1175–1186, 2022.

3. H. Chen, D. Evangelou, K. Loskutova, M. Ghorbani, and D. Grishenkov, “On the development of a novel contrast pulse sequence for polymer-shelled microbubbles,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 68, no. 5, pp. 1569–1579, 2021.

4. R. A. Barmin et al., “Engineering the acoustic response and drug loading capacity of PBCA-based polymeric microbubbles with surfactants,” Mol. Pharm., vol. 19, no. 9, pp. 3256–3266, 2022.

5. S. M. Haftcheshmeh et al., “Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo,” J. Drug Deliv. Sci. Technol., vol. 62, no. 102351, p. 102351, 2021.